In the final week of the Musk v. Altman trial, lawyers traded blows over Elon Musk’s and OpenAI CEO Sam Altman’s credibility. Altman was grilled on his alleged history of lying and self-dealing involving companies that do business with OpenAI. But he fired back, painting Musk as a power-seeker who wanted to control the development…
Whether you’re a founder gearing up for your next raise or a VC scouting your next portfolio win, TechCrunch All Stage, happening July 15 at Boston’s SoWa Power Station, packs more into one day than most multi-day conferences manage to deliver. This isn’t your typical sit-and-listen event. It’s designed to help you build momentum in […]
“The best way to predict the future is to invent it,” the famed computer scientist Alan Kay once said. Uttered more out of exasperation than as inspiration, his remark has nevertheless attained gospel-like status among Silicon Valley entrepreneurs, in particular a handful of tech billionaires who fancy themselves the chief architects of humanity’s future. Sam…
Earlier this week, two new leaders of the US Food and Drug Administration published a list of priorities for the agency. Both Marty Makary and Vinay Prasad are controversial figures in the science community. They were generally highly respected academics until the covid pandemic, when their contrarian opinions on masking, vaccines, and lockdowns turned many…